👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Axon director Kalinowski sells shares worth over $167,000

Published 08/23/2024, 04:48 AM
AXON
-

In a recent transaction, Axon Enterprise, Inc. (NASDAQ:AXON) Director Caitlin Elizabeth Kalinowski sold 450 shares of the company's stock. The sale, which took place on August 21, was executed at an average price of $373.03 per share, resulting in a total value of approximately $167,863.

Following the transaction, Kalinowski's direct holdings in Axon Enterprise now total 7,379 shares. The sale was disclosed in a legal filing with the Securities and Exchange Commission, which is publicly available for investors to review.

Axon Enterprise, Inc., headquartered in Scottsdale, Arizona, is known for its development and manufacture of technology and weapons products for law enforcement and civilians. The company, formerly known as Taser International Inc., has a diverse product line including conducted electrical weapons, body-worn cameras, and software solutions.

The transaction comes at a time when investor interest in insider trading activity is high, as such transactions can provide insights into the perspectives of company executives and directors. While the reasons for Kalinowski's stock sale are not disclosed, investors often monitor these filings to gauge insider sentiment toward the company's current valuation and future prospects.

Shareholders and potential investors in Axon Enterprise can access more details about insider transactions through the company's filings with the SEC.

In other recent news, Axon Enterprise, Inc. reported a record-breaking second quarter, showcasing robust growth with over $500 million in revenue and more than $1 billion in new business bookings. The company's revenue grew by 35% year-over-year, driven by contributions from all business segments, with Cloud and Services leading the way. Axon's future contracted revenue stands at approximately $7.4 billion, with software and services now accounting for 39% of total revenue.

The company's international bookings doubled year-to-date, and Axon secured its largest records contract to date. The launch of new products, TASER 10 and Axon Body 4, fueled growth in TASER and sensors categories. The company also raised its full-year 2024 revenue guidance to between $2 billion and $2.05 billion.

Axon's upcoming acquisition of Dedrone is expected to strengthen its position in the drone market. The company's international business has also gained traction outside the domestic law enforcement sector, with significant interest in corrections and TASER 10 markets. Despite cautiousness regarding potential economic downturns, Axon executives expressed optimism about the resilience of their business, and the potential game-changing impact of AI services.

InvestingPro Insights

As Axon Enterprise, Inc. (NASDAQ:AXON) navigates through its business cycle, recent data from InvestingPro offers a glimpse into the company's financial health and market performance. With a robust market capitalization of approximately $28.21 billion, Axon stands as a significant player in its sector. The company's P/E ratio, a measure of its current share price relative to its per-share earnings, is notably high at 96.8, indicating that investors may be expecting high growth from the company in the future.

InvestingPro data also shows a substantial revenue growth of 32.59% over the last twelve months as of Q2 2024, reflecting a positive trend in the company's sales. This is corroborated by a quarterly revenue growth of 34.57% in Q2 2024, signaling strong performance in the short term. Furthermore, Axon's gross profit margin stands at an impressive 59.81%, suggesting that the company is efficient in its operations and able to retain a significant portion of its sales as profit.

Two notable InvestingPro Tips for Axon Enterprise include the company's expectation to grow its net income this year and the fact that eight analysts have revised their earnings upwards for the upcoming period. These tips indicate that the financial community has a positive outlook on Axon's profitability and future earnings potential. For investors interested in a deeper analysis, there are additional InvestingPro Tips available, which provide further insights into Axon's financial position and market expectations.

As Director Caitlin Elizabeth Kalinowski's recent stock sale may attract attention from investors seeking to understand insider sentiment, these InvestingPro metrics and tips offer a broader context to Axon's financial landscape and may serve as valuable information for shareholders and potential investors evaluating the company's prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.